We are live on
!
Find out more
Verrica Pharmaceuticals
VRCA
VRCA
63 hedge funds and large institutions have $84.2M invested in Verrica Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 22 increasing their positions, 7 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
214% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 7
131% more call options, than puts
Call options by funds: $446K | Put options by funds: $193K
27% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 15
7% more funds holding
Funds holding: 59 → 63 (+4)
0.39% more ownership
Funds ownership: 3.09% → 3.48% (+0.39%)
0% more capital invested
Capital invested by funds: $84.2M → $84.2M (+$83.3K)
Holders
63
Holders Change
+4
Holders Change %
+6.78%
% of All Funds
0.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
22
Reduced
7
Closed
15
Calls
$446K
Puts
$193K
Net Calls
+$253K
Net Calls Change
-$843K
Top Buyers
| 1 |
BlackRock
New York
|
+$5.44M |
| 2 |
State Street
Boston,
Massachusetts
|
+$1.87M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
+$1.85M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.26M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$836K |
Top Sellers
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$1.36M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.2M |
| 3 |
Jane Street
New York
|
-$867K |
| 4 |
Morgan Stanley
New York
|
-$709K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$515K |
